Stage I Ovarian Mesonephric-Like Adenocarcinoma With Mixed Müllerian Features

This ovarian cancer diagnosis at a glance

Stage at diagnosis
Stage I
Subtype
Adenocarcinoma
Biomarkers
KRAS p.G12A; ARHGAP35 p.L1295Cfs*20; PPP2R1A p.R182W; IRS1 p.R410W in endometrioid and mesonephric-like areas; chromosome 1q gain
Sex
Female
Treatment
surgery

Treatment course, step by step

  1. She underwent surgery to remove the uterus, ovaries, and fallopian tubes.

What happened, in summary

A 63-year-old woman was admitted after 3 months of pelvic pain. Ultrasound found a predominantly cystic 12 cm mass involving the left ovary. She underwent total hysterectomy with removal of both ovaries and fallopian tubes. The right adnexa, cervix, and uterus appeared normal, while the left ovarian mass had multiple cystic spaces and a firm 3.5 cm area.

Microscopic review showed a complex mixture of mucinous, endometrioid, and mesonephric-like tissue. A 1.6 cm area had branching papillary, cribriform, and solid growth with increased mitotic activity, supporting mesonephric-like adenocarcinoma. Immunostaining helped distinguish the components: the mesonephric-like areas were positive for CD10, TTF1, and GATA3 and negative for estrogen and progesterone receptors. The overall diagnosis was FIGO stage I ovarian mesonephric-like adenocarcinoma arising in a background of mixed Müllerian proliferations.

Sequencing of the separate tumor components found shared KRAS p.G12A, ARHGAP35, and PPP2R1A mutations with chromosome 1q gain, supporting a common clonal origin rather than separate collision tumors. An IRS1 mutation was limited to the endometrioid and mesonephric-like areas. Together, the shared molecular changes supported a common origin for the different tumor components.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar ovarian cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more ovarian cancer stories